BioSpace News Archive

Newly reported data to be presented in the oral presentation will include pooled results, as well as individual results.

Bicycle Therapeutics and Cancer Research UK announced today that the first patient has been dosed in their Phase I/IIa trial evaluating BT1718 in patients with advanced solid tumors.

Management will host a conference call to review the Company’s results at 8:00 a.m. Eastern Time the same day.

This sterile-packed innovative system adds to the original implant design also available, while providing internal fixation via a dual threaded construct which is inserted between the proximal and middle phalanges so that the opposing threads fixate within the phalangeal canals of the toe to compress the proximal interphalangeal (PIP) joint.

New version of Caregiver is the first FDA cleared non-contact, infrared thermometer intended for professional use that utilizes Bluetooth technology to connect wirelessly to patient monitoring stations and electronic health records systems.

The Company expects a six-month review cycle by FDA.

Test rapidly detects 47 antimicrobial resistance markers directly from urine and bacterial isolates.

The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call:

Shire is preparing to conduct Phase 3 trials investigating SHP647 for the treatment of moderately to severely active Crohn’s disease in adults